WHAT DRIVES US

At Diaceutics we believe that every patient should have access to the right treatment at the right time to positively impact their disease outcome, and we are committed to solving commercialization challenges.

We provide the world's leading pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine through our platform.

DXRX - The Diagnostic Network®

TALK TO AN EXPERT

Copyright © 2024, Diaceutics. All rights reserved

UNLOCK 

MARKET CLARITY

Driving therapy re-adoption requires renewed market clarity, strategic insight and targeted activation 

These real-world results show what’s possible with Diaceutics’ precision-driven approach

11×

more patients identified in FGFR3 rare disease vs traditional claims data

+19%

increase in action targets in CV disease programs

+35.6%

increase in new therapy starts in Precision Oncology

8%

market share growth in HemOnc by prioritizing diagnostic-triggered outreach

Up to 20:1

market share growth driven by smarter adoption

With Diaceutics, it’s not just about overcoming challenges. It’s about outperforming expectation. 

UNCOVER HIDDEN BARRIERS BUILD A SMARTER STRATEGY

The 6A™ Landscape helps you uncover the hidden diagnostic, behavioral, and system barriers that are holding your therapy back turning fragmented signals into a strategic roadmap for renewed adoption and share growth.
Whether defending share in a competitive category or revitalizing a maturing brand, the Landscape equips you to:

The 6A™ Landscape gives you the clarity, structure, and expert-backed recommendations to act decisively ensuring your therapy reaches every patient it was designed to help.

  • Diagnose the real causes of plateau not just the symptoms. 

  • Reframe your brand’s story to align with evolving evidence and behaviors. 

  • Redirect resources toward the most influenceable points in the care pathway. 

  • Accelerate a smarter, data-driven market recovery strategy.

REIGNITE THE KNOWLEDGE

When markets plateau, education isn’t the issue, belief is. Expert Exchange delivers peer to peer education that helps physicians reconnect with evolving science, refreshed evidence, and renewed conviction to act especially when therapy adoption has stalled:

  • Re-establish trust in therapy relevance through real-world evidence and new data.
  • Address hesitation caused by shifting treatment paradigms, outdated perceptions, or lack of peer validation.
  • Re-activate prescribing by delivering insight at the moment of decision, not months after.
  • Sustain momentum through ongoing education that evolves with the market and reinforces adoption behaviors.

ACCELERATE PRESCRIBING DECISIONS WHEN THERAPY ADOPTION FATIGUES

When therapy uptake slows, it’s often
due to a breakdown in engagement not awareness. Physician Engage enables you to overcome adoption fatigue and hesitation by delivering timely, credible education that reignites prescribing confidence in complex or competitive markets:

  • Reach the right physicians within 24 hours of actionable diagnostic or behavioral triggers. 
  • Re-energize stalled prescribers with credible, compliant, peer endorsed content at the moment of clinical relevance. 
  • Reinforce adoption decisions through consistent omnichannel engagement that bridges the gap between testing, diagnosis, and treatment. 
  • Reignite brand relevance through storytelling, evidence, and education aligned to each physician’s real world context

When every moment counts, speed matters. Physician Engage empowers you to reach the right prescribers with the right message fast so you can influence decisions before opportunities are lost..

 

RECLAIM LOST MOMENTUM WITH PRECISION TIMING 

DXRX Signal reconnects brands with real time diagnostic and behavioural triggers, showing where eligible patients are being identified, which physicians are treating them, and when to re-engage:

  • Re-engage targeted physicians within 24 hours of a verified diagnostic signal.
  • Recapture missed patients through alerts that align outreach to real world testing events.
  • Refocus field and digital teams where prescribing traction has faded, scaling engagement efficiently, leveraging your field force activity.
  • Reclaim growth with proven uplift in therapy starts, share, and patient identification. 

See where patients are. Act when it counts. DXRX Signal gives you the precision to drive therapy adoption from day one.

 

Explore how our expert-led approach transforms insight into timely action - reigniting therapy adoption when it matters most.

We’re not just diagnosing the slowdown - we’re reversing it.

At Diaceutics, we help you reignite market momentum through data driven precision, combining real world diagnostic signals, behavioural insights and expert influence to reveal where opportunities have shifted , why uptake has slowed and how to reengage physicians with confidence.

See how real-time diagnostic data identifies eligible patients within 48 hours, enabling targeted, timely HCP engagement. 

Bridge the gap between insight and action, so no eligible patient is left behind.

Reclaim lost momentum with precision timing 

We partner with the world’s leading pharma and emerging biotech to accelerate therapy adoption, whether you are launching, scaling or reigniting momentum.

Supporting cross functional teams in commercial, marketing, medical, data, access and more, we deliver the precision insights and strategies needed to move faster and reach every eligible patient.

Across oncology, rare disease, neurology autoimmune and more, we help you unlock uptake with smarter strategy, real time physician action, and measurable impact.

Let’s reignite your strategy – together

Driving therapy re-adoption requires renewed market clarity, strategic insight and targeted activation

Navigating Precision Commercialization 

Peter Finlayson, Rebecca Fryer & Sarah Kurz

11AM ET

18th November 2025

Partnering for Success in Rare & Precision Therapies

Upcoming Events

Ready to reignite therapy adoption?

ASH Conference 2025

6 - 9th December, Orlando

Source: Data insights from Diaceutics’ client projects 

maximize

PATIENT IMPACT

86%

HCP engagement rate through peer-led education

Reignite interest, drive clinical confidence, and re-establish relevance.